Menu
image description

Category: COVID-19

Researchers Make Strides in Predicting COVID-19 Response, New LRA Study Finds

October 15, 2020 Some people respond to COVID-19 by releasing high amounts of immune proteins called cytokines, which form when the body detects a foreign invader. But release of excessive amounts of cytokines leads to a large immune response that can cause organ damage. With grant support from the Lupus Research Alliance, Dr. Roberto Caricchio […] Read More

LRA-Supported Researcher Finds Similarity between COVID-19 and Lupus Flares

October 21, 2020 In a recent study published in Nature Immunology, LRA Lupus Insight Prize recipient Dr. Ignacio Sanz and colleagues found that the immune response in patients hospitalized with  severe COVID-19 was different from that in patients with mild disease, and that the immune response in severely ill COVID-19 patients was more like a lupus flare. They saw that among severely ill COVID-19 patients, some immune cells called B cells reproduced unchecked, and […] Read More

New LRA-Funded Study: Lupus Flares are Linked to E-Coli Bacteria Levels

August, 2020 A new study led by Dr. Roberto Caricchio, Dr. Stefania Gallucci and Dr. Cagla Tukel, funded by the Lupus Research Alliance, has shown that lupus flares are associated with high levels of antibodies against a specific bacterial protein, called curli. Published in Arthritis and Rheumatology, the study also showed that high levels of […] Read More

New Study Found Hydroxychloroquine Lowered COVID-19 Deaths

July 6, 2020 A study published in the International Journal of Infectious Diseases by Henry Ford Health System found that treatment with hydroxychloroquine significantly lowered the rate of deaths among patients hospitalized with COVID-19. The analysis of more than 2,500 patients across the six hospitals in the Henry Ford Health System found that 13 percent […] Read More

Watch Video of Webcast: Lupus and Cognitive Health

Watch a videotape of our recent webcast: Lupus and Cognitive Health Presented by LRA’s Young Leaders Board People with lupus know only too well the need to avoid stress to prevent flares while optimizing emotional and cognitive wellbeing. But that’s pretty hard to do, especially in this time fraught with societal upheaval amid a global […] Read More

Hydroxycloroquine in COVID-19 Trial Restarted in UK

June 30, 2020 The British Medicines and Healthcare Products Regulatory Agency has approved the restart of a global trial that will explore whether the drugs hydroxychloroquine and chloroquine are able to prevent coronavirus infections. Led by Oxford University’s Mahidol Oxford Tropical Medicine Research Unit, the randomized, placebo-controlled trial will enroll around 40,000 healthcare workers and other at-risk workers […] Read More

Three Healthcare Organizations Issue Statement on FDA Action to End Emergency Authorization of Medications to Treat COVID-19

June 24, 2020 Joint Statement of the American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists on new FDA action to Remove Emergency Use Authorization of Medications to Treat COVID-19 The American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists issued a statement “emphasizing that the FDA’s recent announcement to cancel the emergency […] Read More

FDA Revoked Emergency Use Approval of Hydroxychloroquine for COVID-19

June 15, 2020 The U.S. Food and Drug Administration announced June 15 that it revoked approval called emergency use authorization (EUA) for hydroxychloroquine and chloroquine to be used to treat certain patients who had been hospitalized for COVID-19. The FDA made this decision based on its ongoing analysis of the scientific data from current studies […] Read More

New Guidelines from the ACR For Lupus Care During COVID-19 Pandemic

June 9, 2020 The American College of Rheumatology enlisted 14 experts on infectious diseases and immune system illnesses to develop and publish 25 recommendations on treating lupus and related immune system diseases amid the COVID-19 pandemic.  The Lupus Research Alliance would like to share these with the lupus community as information, but recommend talking to […] Read More

Lupus and COVID-19: What You Need to Know – LIVE WEBCAST May 21 at 6 PM ET

Since the arrival of the novel coronavirus, lupus and the most prescribed drug used to treat it – hydroxychloroquine – have been thrust into the public spotlight despite the mounting scientific evidence that drug does not appear to improve clinical outcomes in patients with COVID-19. What has been talked about less is what the impact […] Read More